<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/xlo" ></link>
<id>urn:uuid:23f1b649-dbcc-85fd-5928-fde163991601</id>
<updated>2026-03-07T23:07:35-05:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>XLO: LUPTAKOVA KATARINA (O) Acquired (JB) 16,625 Shares of XILIO THERAPEUTICS INC for $0.00 on 1/1</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301066" ></link>
<id>urn:uuid:c8b0dd84-6c5a-17b4-7933-9e9da8b35db9</id>
<updated>2026-01-05T16:30:26-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: BRENNAN KEVIN M (VP,FO,AO) Sold (AS) 1,826 Shares of XILIO THERAPEUTICS INC for $0.64 on 1/2</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301071" ></link>
<id>urn:uuid:5de19ff5-16d8-c460-8426-324fe0182c12</id>
<updated>2026-01-05T16:30:23-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: BRENNAN KEVIN M (VP,FO,AO) Acquired (JB) 5k Shares of XILIO THERAPEUTICS INC for $0.00 on 1/1</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301072" ></link>
<id>urn:uuid:48737884-4de0-2db1-3a8e-b720552475f7</id>
<updated>2026-01-05T16:30:23-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: FRANKENFIELD CHRISTOPHER JAMES (CFO) Sold (AS) 7,030 Shares of XILIO THERAPEUTICS INC for $0.64 on 1/2</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301074" ></link>
<id>urn:uuid:9c1ba53f-94d2-d485-44b8-5035fdb635ad</id>
<updated>2026-01-05T16:30:21-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: FRANKENFIELD CHRISTOPHER JAMES (CFO) Acquired (JB) 19,375 Shares of XILIO THERAPEUTICS INC for $0.00 on 1/1</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301075" ></link>
<id>urn:uuid:b4c98e1c-4286-c395-63d4-9848ca45d6bf</id>
<updated>2026-01-05T16:30:21-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: RUSSO RENE (PR,CEO,DIR) Acquired (JB) 44,250 Shares of XILIO THERAPEUTICS INC for $0.00 on 1/1</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6301015" ></link>
<id>urn:uuid:3b264e0f-03af-f065-0659-89d9126ad9a7</id>
<updated>2026-01-05T16:30:18-05:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: SHANNON JAMES SAMUEL (DIR) Bought (B) 45k Shares of XILIO THERAPEUTICS INC for $0.69 on 6/16</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6218696" ></link>
<id>urn:uuid:807f5b54-468d-7463-432d-e13a6bcbf1ef</id>
<updated>2025-06-18T16:57:19-04:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: SHANNON JAMES SAMUEL (DIR) Bought (JB*) 25k Shares of XILIO THERAPEUTICS INC for $0.69 on 6/17</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6218697" ></link>
<id>urn:uuid:df79c823-de27-e942-02d5-1be0058e7ae5</id>
<updated>2025-06-18T16:57:19-04:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: RUSSO RENE (PR,CEO,DIR) Bought (B) 36,289 Shares of XILIO THERAPEUTICS INC for $0.68 on 6/16</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6218695" ></link>
<id>urn:uuid:050999ec-3cdf-b1fc-f2b0-8f2350cd9628</id>
<updated>2025-06-18T16:56:47-04:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
<entry>
<title>XLO: BELLO AKINTUNDE OLATOKUMBO (DIR) Filed a Form 3, Becoming a Registered Insider at XILIO THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/xlo/xilio-therapeutics-inc/id-6214831" ></link>
<id>urn:uuid:7c64e3cd-1549-dc63-fd91-c57938ee03f0</id>
<updated>2025-06-12T16:33:58-04:00</updated>
<summary type="html" ><![CDATA[XILIO THERAPEUTICS INC (XLO). Recent Price: $0.53. Mkt Cap:38.9mm. 10D Vol: 399,690]]></summary>
</entry>
</feed>